Editor's Blog17 mins ago
This Man Should Step Down Immediately
20 Answers
Talk about a conflict of interest, no wonder all the doom mongering.
https:/ /www.th esun.co .uk/new s/12754 482/sir -patric k-share s-vacci ne-gsk/
https:/
Answers
Best Answer
No best answer has yet been selected by youngmafbog. Once a best answer has been selected, it will be shown here.
For more on marking an answer as the "Best Answer", please visit our FAQ.Ken here's how it works. When you are given the option, the share purchase price is set, usually at the level when you get the option. The option matures and you are then told how much it will cost you to buy the shares. You usually have three choices, you can buy the shares at the set price, you can decline to buy, you can do a buy and immediately sell deal where the shares you had the option on are sold and you receive the difference between the option price and the price the shares sold for.
personally I think it would have been criminally stupid for the gov.t to rule out GSK on the basis that PV has got a share option from his time at work there and unreasonable to expect him to surrender an option that he earned long before the current pandemic.
personally I think it would have been criminally stupid for the gov.t to rule out GSK on the basis that PV has got a share option from his time at work there and unreasonable to expect him to surrender an option that he earned long before the current pandemic.
// True. He can't sell shares he doesn't yet own.//
erm that is why I wondered if this were suitable for the 14 y o of AB
you do sell shares you dont own in a process called shorting
which in my hands is a process for losing loolah
but good 'shorters' make a bomb
( and if they are not good they turn into AB posters)
erm that is why I wondered if this were suitable for the 14 y o of AB
you do sell shares you dont own in a process called shorting
which in my hands is a process for losing loolah
but good 'shorters' make a bomb
( and if they are not good they turn into AB posters)
PP its done with oil as well....well maybe not right now.... its called spinning. One time my DH was offered a "you name it" bribe if he would tell an acquaintance who actually owned a parcel of crude....He knew because he was fairly senior in the upstream end of the UK branch of an oil national. Needless to say the acquaintance became an ex acquaintance and we didn't make our fortunes. Around 10 years later colleagues of his thought to make their fortunes by awarding drydock contracts in exchange for some serious bungs and ended up in jail. Vengeance is mine saith the company, I will repay.
From Natasha Loder, Health Policy Editor at the Economist
GSK is not actually making this vaccine. It is Sanofi's vacccine. GSK is sharing its technology to make vaccines better (called an adjuvant) to any firm that wants them. (And quite a lot do.)
Earlier this year, CEO Emma Walmsley said they wanted to help by sharing their adjuvant, and it wasn't a commercial venture. Because, pandemic.
It was popular and is now used by covid vaccine makers such as @sanofi. Vir. @Innovax. Clover. Medicago Inc. Remarkable, actually.
So GSK are making a billion doses of adjuvant. They started, at risk, in May.
In the event GSK's tie-ups make money, firm says, "it will be invested in support of coronavirus related research and long-term pandemic preparedness, either through GSK’s internal investments, or with external partners."
Why? Because, pandemic.
Even if Vallance had some control over the UK's vaccine buying (and even the Telegraph admits in almost last paragraph that ministers make the decision)... and even if Sanofi does make a profit.... and even some of this goes to GSK, ......shareholders are not going to benefit.
But why spoil a juicy story with a few boring facts?
GSK is not actually making this vaccine. It is Sanofi's vacccine. GSK is sharing its technology to make vaccines better (called an adjuvant) to any firm that wants them. (And quite a lot do.)
Earlier this year, CEO Emma Walmsley said they wanted to help by sharing their adjuvant, and it wasn't a commercial venture. Because, pandemic.
It was popular and is now used by covid vaccine makers such as @sanofi. Vir. @Innovax. Clover. Medicago Inc. Remarkable, actually.
So GSK are making a billion doses of adjuvant. They started, at risk, in May.
In the event GSK's tie-ups make money, firm says, "it will be invested in support of coronavirus related research and long-term pandemic preparedness, either through GSK’s internal investments, or with external partners."
Why? Because, pandemic.
Even if Vallance had some control over the UK's vaccine buying (and even the Telegraph admits in almost last paragraph that ministers make the decision)... and even if Sanofi does make a profit.... and even some of this goes to GSK, ......shareholders are not going to benefit.
But why spoil a juicy story with a few boring facts?
Related Questions
Sorry, we can't find any related questions. Try using the search bar at the top of the page to search for some keywords, or choose a topic and submit your own question.